- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VERV
Recent news which mentions VERV
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
June 06, 2024
From Benzinga
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
May 28, 2024
From Benzinga
From InvestorPlace
3 Underappreciated Stocks That Could 10x in 10 Years
May 12, 2024
From InvestorPlace
Tickers
VERV
From InvestorPlace
From Benzinga
From Benzinga
Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade
April 04, 2024
From Benzinga
From Benzinga
From Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 02, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 02, 2024
From Benzinga
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
April 02, 2024
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 02, 2024
From Benzinga
3 Stocks That Could Be the Next Big Thing in Gene Editing
March 21, 2024
From InvestorPlace
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
February 19, 2024
From InvestorPlace
3 Gene Editing Stocks With Unprecedented Surge Potential
February 13, 2024
From InvestorPlace
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
February 12, 2024
From Motley Fool
From InvestorPlace
Why Beam Therapeutics Stock Zoomed 17% Higher Today
January 29, 2024
From Motley Fool
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
From InvestorPlace
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
From InvestorPlace
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
December 31, 2023
From Motley Fool
From Benzinga
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
From Motley Fool
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 29, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.